Cleared Traditional

K211219 - LASSOSTAR NAV Circular Mapping Catheter

K211219 is an FDA 510(k) clearance for LASSOSTAR NAV Circular Mapping Catheter, manufactured by Biosense Webster, Inc.. The device is a Class 2 Cardiovascular device with product code DRF cleared through the Traditional 510(k) pathway after a 278-day FDA review.

K211219 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
278d
Days
Class 2
Risk

K211219 is an FDA 510(k) clearance for the LASSOSTAR NAV Circular Mapping Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Irvine, US). The FDA issued a Cleared decision on January 26, 2022 after a review of 278 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

FDA 510(k) Submission Details - K211219

510(k) Number K211219 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2021
Decision Date January 26, 2022
Days to Decision 278 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
153d slower than avg
Panel avg: 125d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRF Device Classification - Class 2, Special Controls

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 140
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K211219.
IntellaMap Orion High Resolution Mapping Catheter
K220796 · Boston Scientific Corporation · Jun 2022
RithmID-SD Steerable Diagnostic Electrophysiology Catheter
K203793 · Synaptic Medical Corporation · Feb 2022
Khelix Steerable Electrophysiology Catheters, Khelix Loop Fixed Electrophysiology Catheters, Khelix Fixed Loop Steerable Electrophysiology Catheters, Khelix Variable Loop Steerable Electrophysiology Catheters
K211327 · CathRx, Ltd. · Feb 2022
ViaCath, AcQRate Dx Steerable Catheter
K212593 · Biotronick, Inc. · Oct 2021
Polaris X Unidirectional Steerable Diagnostic Catheter
K211494 · Boston Scientific Corporation · Sep 2021
Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter
K211375 · Boston Scientific Corporation · Sep 2021